It's been another tough week for ASX healthcare but Morgans' Scott Power said there's been bright spots with Racura soaring on trial news.
An Anglesey man wants to know why it took so long for Betsi health chiefs to start treatment on his "aggressive cancer" - a ...
BCUHB patient waited three times longer than he should have for prostate cancer treatment. Delays likely advanced his condition, ombudsman finds.
Delays in treating a patient with an aggressive form of prostate cancer more than likely contributed to his disease advancing ...
Researchers presented clinical study results on the dual-tracer PET imaging technique at the European urology conference with peer-reviewed publication forthcoming.
Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.
When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT showed promise for reducing the number of biopsies without compromising the ...
Tagawa, MD, identified 3 primary clinical scenarios where PSMA PET scans have become the established standard for prostate cancer care. The first application is initial s ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...
A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results